EP013 Evaluation of postoperative analgesia with intrathecal morphine after laparoscopic or robotic nephrectomy: a randomized controlled trial

<h3></h3> <b>Please confirm that an ethics committee approval has been applied for or granted</b>: Yes: I’m uploading the Ethics Committee Approval as a PDF file with this abstract submission <h3>Background and Aims</h3> Postoperative pain management in minimally invasive nephrectomy remains a critical aspect of patient care. This study explores the potential of low dose intrathecal preservative free morphine as a promising analgesic modality for enhancing postoperative pain control while minimizing systemic opioid requirements and associated side effects, thereby improving patient outcomes. <h3>Methods</h3> Patients scheduled for elective laparoscopic or robotic-assisted nephrectomy were included in this single-center, double-blind, prospective randomized placebo-controlled trial. Preoperatively patients were randomly assigned using computer generated block randomisation sequence to receive intrathecal morphine 200 mcg with 1 ml 0.5% Bupivacaine hydrochloride in dextrose injection (Group-M) or a sham procedure (Group-C). All patients received standard intraoperative multimodal analgesia and postoperative patient-controlled analgesia with intravenous morphine. Primary outcome was 24-hour intravenous morphine consumption. Secondary outcomes were intraoperative and 48-hour postoperative fentanyl requirement, static pain scores, dynamic pain on first ambulation and on coughing, postoperative complications, postoperative length of hospital stay and patient satisfaction score. P-value &lt; 0.05 was considered as significant. <h3>Results</h3> A total of sixty-two patients were recruited. The intravenous morphine consumption 24 hours after surgery was significantly lower in Group-M (16.5 ± 12.3 mg) versus Group-C (27.2 ± 12.1 mg), p=0.001. There were significant differences in static pain scores up to first 12 hours and dynamic pain on first ambulation and coughing. Intraoperative and 48-hour postoperative rescue fentanyl requirements were significantly lower in Group-M, p&lt;0.05 (table 1). <h3>Conclusions</h3> Intrathecal morphine significantly reduces postoperative morphine requirement and postoperative pain scores.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/rapm-2024-esra.86
Primary Topic
Pain Management and Opioid Use
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EP013 Evaluation of postoperative analgesia with intrathecal morphine after laparoscopic or robotic nephrectomy: a randomized controlled trial

Tarun Jindal, Srimanta Kumar Haldar, Anshuman Sarkar, Gaurav Aggarwal et al.
Pain Management and Opioid Use
article

EP013 Evaluation of postoperative analgesia with intrathecal morphine after laparoscopic or robotic nephrectomy: a randomized controlled trial

Tarun Jindal, Srimanta Kumar Haldar, Anshuman Sarkar, Gaurav Aggarwal, Aditi Gupta, Sumantra Sarathi Banerjee
article en

Abstract

<h3></h3> <b>Please confirm that an ethics committee approval has been applied for or granted</b>: Yes: I’m uploading the Ethics Committee Approval as a PDF file with this abstract submission <h3>Background and Aims</h3> Postoperative pain management in minimally invasive nephrectomy remains a critical aspect of patient care. This study explores the potential of low dose intrathecal preservative free morphine as a promising analgesic modality for enhancing postoperative pain control while minimizing systemic opioid requirements and associated side effects, thereby improving patient outcomes. <h3>Methods</h3> Patients scheduled for elective laparoscopic or robotic-assisted nephrectomy were included in this single-center, double-blind, prospective randomized placebo-controlled trial. Preoperatively patients were randomly assigned using computer generated block randomisation sequence to receive intrathecal morphine 200 mcg with 1 ml 0.5% Bupivacaine hydrochloride in dextrose injection (Group-M) or a sham procedure (Group-C). All patients received standard intraoperative multimodal analgesia and postoperative patient-controlled analgesia with intravenous morphine. Primary outcome was 24-hour intravenous morphine consumption. Secondary outcomes were intraoperative and 48-hour postoperative fentanyl requirement, static pain scores, dynamic pain on first ambulation and on coughing, postoperative complications, postoperative length of hospital stay and patient satisfaction score. P-value &lt; 0.05 was considered as significant. <h3>Results</h3> A total of sixty-two patients were recruited. The intravenous morphine consumption 24 hours after surgery was significantly lower in Group-M (16.5 ± 12.3 mg) versus Group-C (27.2 ± 12.1 mg), p=0.001. There were significant differences in static pain scores up to first 12 hours and dynamic pain on first ambulation and coughing. Intraoperative and 48-hour postoperative rescue fentanyl requirements were significantly lower in Group-M, p&lt;0.05 (table 1). <h3>Conclusions</h3> Intrathecal morphine significantly reduces postoperative morphine requirement and postoperative pain scores.

Tata Medical Center (IN)
Good health and well-being
Openalex Percentile: Top 72%
Pain Management and Opioid Use
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.